Anne Samuel
Stock Analyst at JP Morgan
(2.56)
# 2,354
Out of 5,032 analysts
70
Total ratings
53.49%
Success rate
1.56%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HQY HealthEquity | Maintains: Overweight | $125 → $126 | $91.48 | +37.74% | 9 | Sep 3, 2025 | |
VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $283.73 | +2.21% | 7 | Aug 28, 2025 | |
PGNY Progyny | Maintains: Neutral | $23 → $25 | $19.34 | +29.27% | 8 | Aug 26, 2025 | |
DOCS Doximity | Maintains: Neutral | $63 → $60 | $67.57 | -11.20% | 7 | May 27, 2025 | |
IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $204.55 | -13.47% | 7 | May 19, 2025 | |
OMCL Omnicell | Maintains: Neutral | $44 → $36 | $29.90 | +20.40% | 5 | Mar 20, 2025 | |
EVH Evolent Health | Maintains: Overweight | $13 → $12 | $7.53 | +59.36% | 12 | Mar 10, 2025 | |
PHR Phreesia | Maintains: Overweight | $27 → $28 | $22.29 | +25.62% | 2 | Sep 9, 2024 | |
PINC Premier | Maintains: Neutral | $21 → $19 | $28.00 | -32.14% | 4 | Sep 9, 2024 | |
CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $25.26 | -16.86% | 3 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $13 | $3.05 | +326.23% | 3 | Sep 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $36.98 | -26.99% | 2 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.87 | +74.22% | 1 | Jul 31, 2024 |
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $91.48
Upside: +37.74%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $283.73
Upside: +2.21%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $19.34
Upside: +29.27%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $67.57
Upside: -11.20%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $204.55
Upside: -13.47%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $29.90
Upside: +20.40%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.53
Upside: +59.36%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $22.29
Upside: +25.62%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $28.00
Upside: -32.14%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $25.26
Upside: -16.86%
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.05
Upside: +326.23%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $36.98
Upside: -26.99%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.87
Upside: +74.22%